Custom insoles versus sham and GP-led usual care in patients with plantar heel pain: Results of the STAP-study - A randomised controlled trial

Autor: Marienke van Middelkoop, Patrick J E Bindels, Amy Dieker, Michael Skovdal Rathleff, Nadine Rasenberg, Peter L.J. van Veldhoven, Sita M A Bierma-Zeinstra, Lars Fuit
Přispěvatelé: General Practice
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Zdroj: Rasenberg, N, Bierma-Zeinstra, S M A, Fuit, L, Rathleff, M S, Dieker, A, Van Veldhoven, P, Bindels, P J E & Van Middelkoop, M 2021, ' Custom insoles versus sham and GP-led usual care in patients with plantar heel pain : Results of the STAP-study-A randomised controlled trial ', British Journal of Sports Medicine, vol. 55, no. 5, pp. 272-278 . https://doi.org/10.1136/bjsports-2019-101409
British Journal of Sports Medicine
British Journal of Sports Medicine, 55(5), 272-278. BMJ Publishing Group
ISSN: 1473-0480
0306-3674
Popis: ObjectivesTo compare custom-made insoles to sham insoles and general practice (GP)-led usual care in terms of pain at rest and during activity at 12 weeks follow-up in individuals with plantar heel pain.MethodsIn this randomised clinical trial 185 patients aged 18 to 65 years, with a clinical diagnosis of plantar heel pain for at least 2 weeks, but no longer than 2 years were recruited. Patients were randomly allocated into three groups: (1) GP-led treatment, plus an information booklet with exercises (usual care; n=46), (2) referral to a podiatrist for treatment with a custom-made insole plus an information booklet with exercises (custom-made insole; n=70) and (3) referral to a podiatrist and treatment with a sham insole plus an information booklet with exercises (sham insole; n=69). As well as the primary outcome of pain severity (11-point Numerical Rating Scale) we used the Foot Function Index (0 to 100) as a secondary outcome.ResultsOf 185 randomised participants, 176 completed the 12-week follow-up. There was no difference in pain or function between the insole and the sham groups at 12 weeks. Participants in the GP-led usual care group reported less pain during activity at 12 weeks, (mean difference (MD) 0.94, 95% CI 0.23 to 1.65), less first step pain (MD 1.48, 95% CI 0.65 to 2.31), better function (MD 7.37, 95% CI 1.27 to 13.46) and higher recovery rates (RR 0.48, 95% CI 0.24 to 0.96) compared with participants in the custom insole group.ConclusionsReferral to a podiatrist for a custom-made insole does not lead to a better outcome compared to sham insoles or compared to GP-led usual care.Trial registration numberNTR5346.
Databáze: OpenAIRE